This work is supported by a grant from the National Institutes of Health AR-41802.
Eccentric contractions disrupt FKBP12 content in mouse skeletal muscle
Article first published online: 17 JUL 2014
© 2014 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of the American Physiological Society and The Physiological Society.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Volume 2, Issue 7, July 2014
How to Cite
Eccentric contractions disrupt FKBP12 content in mouse skeletal muscle. Physiol Rep, 2 (7), 2014, e12081, doi:10.14814/phy2.12081, , , ,
- Issue published online: 3 JUL 2014
- Article first published online: 17 JUL 2014
- Manuscript Revised: 13 JUN 2014
- Manuscript Accepted: 13 JUN 2014
- Manuscript Received: 13 MAR 2014
- National Institutes of Health. Grant Number: AR-41802
- skeletal muscle
Strength deficits associated with eccentric contraction-induced muscle injury stem, in part, from impaired voltage-gated sarcoplasmic reticulum (SR) Ca2+ release. FKBP12 is a 12-kD immunophilin known to bind to the SR Ca2+ release channel (ryanodine receptor, RyR1) and plays an important role in excitation-contraction coupling. To assess the effects of eccentric contractions on FKBP12 content, we measured anterior crural muscle (tibialis anterior [TA], extensor digitorum longus [EDL], extensor hallucis longus muscles) strength and FKBP12 content in pellet and supernatant fractions after centrifugation via immunoblotting from mice before and after a single bout of either 150 eccentric or concentric contractions. There were no changes in peak isometric torque or FKBP12 content in TA muscles after concentric contractions. However, FKBP12 content was reduced in the pelleted fraction immediately after eccentric contractions, and increased in the soluble protein fraction 3 day after injury induction. FKBP12 content was correlated (P = 0.025; R2 = 0.38) to strength deficits immediately after injury induction. In summary, eccentric contraction-induced muscle injury is associated with significant alterations in FKBP12 content after injury, and is correlated with changes in peak isometric torque.
Unaccustomed exercise is known to injure skeletal muscle. It is generally accepted that eccentric contractions, which decelerate limbs during exercise are the primary cause of muscle injury due to their intrinsic capacity to produce high levels of stress. Eccentric contraction-induced skeletal muscle injury is characterized by damage to sarcomeres and plasma membranes, inflammation and swelling, release of skeletal muscle proteins into circulation, reduced range of motion, and delayed onset muscle soreness and stiffness (Clarkson and Hubal 2002; Warren et al. 2002b; Allen et al. 2005; Hyldahl and Hubal 2013). Functionally, eccentric contraction-induced muscle injury is associated with immediate and long-lasting reductions in muscle strength (Lowe et al. 1995; Ingalls et al. 1998a,b; Warren et al. 1999; Rathbone et al. 2003). Ultimate recovery of peak muscle strength can take weeks and requires the upregulation of protein synthesis and satellite cell activity (Lowe et al. 1995; Rathbone et al. 2003). Given the magnitude and duration of the functional deficits caused by eccentric contractions, it is likely that multiple mechanisms contribute to the loss and recovery of force production.
Although impaired voltage-gated sarcoplasmic reticulum (SR) Ca2+ release is known to contribute to strength deficits early (i.e., 0–3 day) after exercise-induced muscle injury (Balnave and Allen 1995; Ingalls et al. 1998b), the exact mechanism of SR dysfunction remains unclear. In skeletal muscle, excitation-contraction (E-C) coupling can be defined as Ca2+ release from the SR after the voltage-sensitive dihydropyridine receptor (DHPR) embedded in the T-tubule directly activates the ryanodine receptor 1 (RyR1) located in the SR membrane. RyR1, a large homotetrameric protein complex, interacts with numerous proteins (e.g., DHPR, FKBP12, junctophilin, calmodulin, calsequestrin) that serve to regulate SR Ca2+ release (Chelu et al. 2004; Kushnir et al. 2010; Lanner et al. 2010). We have shown that eccentric contractions reduce junctophilin 1 and 2 (JP1 and JP2), proteins that normally maintain close apposition of T-tubule and SR membranes, and the loss of these proteins contribute to early strength deficits (Corona et al. 2013). JP proteins may be reduced immediately after performance of eccentric contractions via Ca2+-dependent proteolysis given the elevation in cytosolic [Ca2+] (Balnave and Allen 1995; Lynch et al. 1997; Ingalls et al. 1998b) and the potential of calpain cleavage of JP proteins (Murphy et al. 2013). Decreases in JP content are associated with increased distance between DHPR and RyR1, and decreases in voltage-gated SR Ca2+ release (Ito et al. 2001; Komazaki et al. 2002; Hirata et al. 2006; Golini et al. 2011). Therefore, strength deficits associated with eccentric contraction-induced muscle injury may stem from less efficient signaling between the DHPR and RyR1 proteins.
Alternatively, strength deficits stemming from SR dysfunction after the performance of eccentric contractions may also result from alterations in intrinsic RyR1 function. In support of this notion, drug-induced SR Ca2+ release rates are significantly reduced immediately after the performance of eccentric contractions (Ingalls et al. 1998b) although RyR1 protein content is unaltered (Ingalls et al. 2004). Given the large number of proteins known to interact with RyR1, it is possible that eccentric contractions may disrupt binding of these critical proteins and alter RyR1 function. One such protein is FKBP12, a 12 kDa protein that binds the immunosuppressive drugs FK506 and rapamycin. Normally, FKBP12 binds to the subunits of the RyR1 homotetramer, and stabilizes a closed state of the SR Ca2+ channel and prevents channel opening to subconductance states (Brillantes et al. 1994; Ahern et al. 1997). Decreasing FKBP12 content via genetic modifications reduces voltage-gated SR Ca2+ release in myotubes (Avila et al. 2003; Tang et al. 2004). Furthermore, Bellinger et al. (2008) demonstrated chronic exhaustive exercise depletes RyR1 of FKBP12, promotes leaky RyR1 channels and enhances fatigability, and drugs that prevent the removal of FKBP12 attenuated these detrimental effects. Although chronic exhaustive exercise is associated with FKBP12 depletion and SR Ca2+ leak (Bellinger et al. 2008), there have been no studies that have examined the effects of eccentric contractions on FKBP12 content in skeletal muscle. Therefore, the purpose of this study was to test the hypotheses that eccentric contractions disrupt FKBP12 content in mouse skeletal muscle, and that the loss of FKBP12 is associated with skeletal muscle dysfunction.
Material and Methods
Female C57BL6 mice 2–4 months old were used in this study. The mice were housed in groups of 5 animals per cage, supplied with food and water ad libitum, and maintained in a room at 20–22°C with a 12-h photoperiod. Mice were euthanized with an overdose of isoflurane followed by either cervical dislocation or thoracotomy. All animal care and use procedures were approved by the institutional animal care and use committee and met the guidelines set by the American Physiological Society.
The overall experimental design of the study is illustrated in Figure 1. Mouse anterior crural muscle [tibialis anterior (TA), extensor digitorum longus (EDL), and extensor hallucis muscles] strength was assessed in vivo before and after a single bout of 150 concentric or eccentric contractions. Specifically, isometric torque produced by this muscle group as a function of stimulation frequency (20–300 Hz) was measured in anesthetized mice before and immediately after (n = 38) the eccentric contraction bout, and in subgroups of these mice at 3 (n = 13) and 14 (n = 10) days. Due to the rapid recovery of mouse anterior crural muscle strength following concentric contractions (Warren et al. 1999), isometric torque was measured before and immediately after (n = 16) the concentric contraction bout, and then only at 3 days (n = 8) in a subgroup of these mice. Preexercise torque served as control for all in vivo measurements.
FKBP12 protein content was determined in the left TA muscle from mice that performed either 150 concentric or eccentric contractions and in the nonexercised contralateral TA muscles, which served as controls for the Western blot analyses. Therefore, FKBP12 content was determined in the TA muscles immediately after (n = 7) the performance of eccentric contractions, and at 3 (n = 8) and 14 (n = 8) days. FKBP12 content was also determined in the TA muscles immediately after (n = 4) the performance of concentric contractions, and at 3 (n = 6) days. Nonexercised contralateral TA muscles (n = 15) served as controls. FKBP12 can be bound to either the RyR1 protein or free in the cytosol, therefore the TA muscle homogenate was centrifuged to obtain a pellet fraction containing RyR1 and a supernatant fraction containing free FKBP12. FKBP12 protein content in each fraction was assessed via Western blot.
Isometric force production of isolated EDL muscle as a function of stimulation frequency (10–300 Hz) and caffeine force was assessed ex vivo from control mice (n = 10) that performed no in vivo exercise, and mice that had previously performed concentric (0 [n = 8] or 3 day [n = 8] post) or eccentric (0 [n = 11], 3 [n = 8], or 14 day [n = 8] post) exercise. EDL muscle exposure to 2 mmol L−1 caffeine was used to assess potential changes in the sensitivity of RyR1 to caffeine at concentrations known to induce twitch potentiation. Because 50 mmol L−1 caffeine elicits SR Ca2+ release by acting directly on RyR1 and therefore by-passes the upstream components of E-C coupling (Herrmann-Frank et al. 1999; Lamb et al. 2001), relative reductions in 50 mmol L−1 caffeine induced- and electrically stimulated-force were compared to serve as an indirect marker of E-C coupling failure (Warren et al. 1993; Ingalls et al. 1998b; Corona et al. 2010).
In vivo muscle strength analysis and injury induction
Contractile function (i.e., torque–frequency relationship) of the left anterior crural muscles was measured in vivo immediately before and after, as well as 3 or 14 days after a single bout of 150 eccentric contractions, and 3 days after a bout of 150 concentric contractions as previously described (Lowe et al. 1995; Ingalls et al. 1998a,b; Warren et al. 1999; Corona et al. 2008a,b; Corona and Ingalls 2013). Briefly, mice were anesthetized with isoflurane (1.5% isoflurane and 400 mL O2 per min) and placed on a temperature controlled platform to maintain core body temperature between 35 and 37°C. The left knee was clamped and the left foot was secured to an aluminum “shoe” that is attached to the shaft of an Aurora Scientific 300B servomotor (Aurora, ON, Canada). Sterilized needles were inserted through the skin for stimulation of the left common peroneal nerve. Stimulation voltage and needle electrode placement were optimized with 5–15 isometric contractions (200 ms train of 0.1 ms pulses at 300 Hz). Contractile function of the anterior crural muscles was assessed by measuring peak isometric torque as a function of stimulation frequency (20–300 Hz). The anterior crural muscles performed either concentric or eccentric contractions through a 38° angular movement at 2000 s−1 starting from a 19° plantarflexed or dorsiflexed position, respectively. The eccentric and concentric contractions were preceded by a 100 ms isometric stimulation (Fig. 2A).
Ex vivo analysis of EDL muscle
Extensor digitorum longus muscles were dissected free and studied using an ex vivo preparation as previously described (Ingalls et al. 1998a,b, 2004; Corona et al. 2008a, 2010; Corona and Ingalls 2013). The muscles were mounted in an organ bath containing a Krebs-Ringer bicarbonate buffer (pH 7.4) with (in mmol L−1) 144 Na+, 126.5 Cl−, 6 K+, 1 Mg2+, 1 , 1 , 25 , 1.25 Ca2+, 0.17 leucine, 0.10 isoleucine, 0.20 valine, 10 glucose, and 10 μg mL−1 gentamicin sulfate and 0.10 U mL−1 insulin (the buffer was equilibrated with 95% O2–5% CO2 gas). The distal tendon was attached by silk suture and attached to a fixed support, and the proximal tendon was attached to the lever arm of a servomotor system (Aurora Scientific 300B). Optimal physiological muscle length (Lo) in the chamber was set with a series of twitch contractions (0.2 ms pulse at 150 V). Peak isometric force as a function of stimulation frequency (10–300 Hz) was measured at 35°C during isometric contractions (200 ms trains of 0.2 ms pulses), with 3 min between contractions. Caffeine sensitivity and peak caffeine contracture force were assessed by measuring changes in baseline force during exposure to caffeine (2 and 50 mmol L−1) and twitch contractions at a rate of 0.2 Hz. Force (N) produced by the EDL muscle was normalized to physiological cross-sectional area (PCSA) as described previously (Lowe et al. 1995; Ingalls et al. 1998a,b, 2004; Corona et al. 2008a, 2010; Corona and Ingalls 2013).
Following dissection, skeletal muscles were weighed, frozen in liquid nitrogen, and stored at −72°C until further use. Muscles were homogenized in a buffer of the following constituents (in mmol L−1): 250 sucrose, 100 KCl, 20 MOPS, and 5 EDTA (pH 6.8). Because FKBP12 can exist attached to RyR1 or as a soluble protein, muscle homogenate was centrifuged at 10,000 g for 15 min at 4°C to obtain a pelleted fraction and a soluble protein fraction. Protein content was determined spectrophotometrically using the Bradford assay. Pelleted (100 μg) and soluble (150 μg) protein fractions were loaded onto a 12% polyacrylamide gel (Acrylamide to Bis-; 37.5:1) and separated according to molecular weight (100 V for 30 min; 150 V for 45 min). The protein was then transferred to a nitrocellulose membrane (constant 1.3 A, up to 25V for 7 min). Following transfer, the membrane was blocked overnight at ~4°C in 5% nonfat dried milk (w/v) in tris-buffered saline with 0.1% Tween-20 (TBS-T). The following morning, the membranes were then probed with rabbit anti-mouse FKBP12 primary antibody (PA1-026; Thermo Scientific, Rockford, IL) for 2 h at room temperature on an orbital shaker. FKBP12 antibody was diluted to 1:1667, while GAPDH antibody (MAB374; Millipore, Billerica, MA) was diluted 1:1000 in TBS-T. Following incubation in primary antibody, membranes were washed with TBS-T (3 × 15 min) and then probed with horseradish peroxidase conjugated goat anti-rabbit IgG secondary antibody (G21234; Invitrogen, Grand Island, NY) diluted in TBS-T (1:20,000) for 1 h at room temperature with shaking. The membranes were then washed as described above and treated with enhanced chemilumescent solution (Thermo Scientific) prior to detection using a BioRad ChemiDoc imaging station (Hercules, CA). FKBP12 optical density from the soluble protein fraction was normalized to the GAPDH content, whereas FKBP12 from the pelleted fraction was normalized to the protein band corresponding to actin from a Ponceau-stained membrane due to the lack of GAPDH in this fraction.
Data modeling and statistics
Torque– and force–frequency relationships were modeled with the following equation:
Where x is the stimulation frequency, min and max are the smallest (i.e., twitch) and largest (i.e., peak tetanic) respective forces estimated. EC50 is the stimulation frequency at which half the amplitude of force (max – min) is reached and n is the coefficient describing the slope of the steep portion of the curve.
Torque– and force–frequency parameters, anthropometric measurements, and protein content values were analyzed separately using a one-way ANOVA. Eccentric and concentric contractions during each type of exercise bout, as well as pre- and postexercise protocol force values were analyzed using a group by contraction or time split-plot ANOVA. Post hoc means comparisons testing was performed when a significant ANOVA was observed. Statistical significance was achieved with P ≤ 0.05. All statistical testing was performed with SigmaPlot (San Jose, CA).
The body weight of the control mice (22.3 ± 0.4 g) was significantly less (P = 0.02) than the weight of the mice in the concentric (24.4 ± 0.6 g) and eccentric (24.3 ± 0.4 g) exercise groups. This body weight difference is explained by a difference in age; mice in the control group were approximately 6 weeks of age, whereas, the age of the other mice was approximately 8–10 weeks. The initial body weight of mice performing in vivo contraction protocols (i.e., concentric and eccentric) were not different (P = 0.59) from each other. Although there were no significant differences (P ≥ 0.076) in body weight among any of groups after concentric and eccentric contraction protocols, isometric torque produced by anterior crural muscles was normalized to body weight to allow comparisons of torque with our previous published studies.
150 eccentric and concentric contractions in vivo
Peak torque produced by anterior crural muscles during the first contraction of the eccentric contraction protocol was 108% greater (P < 0.001) than peak torque produced during the first contraction of the concentric contraction protocol (Fig. 2B). Although peak torque significantly (P < 0.001) decreased over the 150 contractions in both eccentric and concentric contraction protocols, the decrease in peak eccentric torque (54.6 ± 1.2%) was greater (P < 0.001) than the reduction in peak torque for the concentric contractions (9.5 ± 2.1%).
In vivo isometric torque
Before performing concentric and eccentric contractions, there were no differences (P ≥ 0.20) in normalized isometric torque (i.e., 20–300 Hz) or Hill equation coefficients between groups of mice (Fig. 2C and D, Table 1). Performing 150 concentric contractions resulted in low-frequency fatigue as we have shown previously (Warren et al. 1999). Peak isometric twitch torque was reduced 38.5 ± 2.6% (P = 0.001) immediately after concentric exercise but had returned to normal values by 3 days (P = 0.97). Peak isometric tetanic torque (i.e., 300 Hz) was not significantly (P = 0.29) reduced at any time following concentric exercise (Fig. 2C). The stimulation frequency that produces 50% of peak isometric tetanic torque (EC50) was increased (P = 0.02) immediately after the concentric contractions, and returned to preexercise values by 3 days (P = 0.93) (Table 1).
|Pre||0 day||3 day||Pre||0 day||3 day||14 day|
|Body weight (g)||24.4 ± 0.6||24.4 ± 0.6||23.9 ± 0.5||24.3 ± 0.4||24.3 ± 0.4||23.7 ± 0.5||23.9 ± 0.7|
|Minmeas (N mm kg−1)||23.7 ± 1.0||14.4 ± 0.7a||23.3 ± 1.0||22.6 ± 0.6||2.3 ± 0.2b||4.4 ± 0.8b||22.0 ± 1.0|
|Maxmeas (N mm kg−1)||99.9 ± 3.2||102.6 ± 3.4||93.9 ± 2.9||98.8 ± 1.5||50.2 ± 1.4bc||43.6 ± 3.9bc||84.9 ± 2.5d|
|Minestim (N mm kg−1)||21.8 ± 0.9||12.2 ± 0.5a||21.7 ± 1.0||20.6 ± 0.6||1.9 ± 0.2b||4.2 ± 0.8b||19.7 ± 0.8|
|Maxestim (N mm kg−1)||97.5 ± 3.3||101.0 ± 3.6||91.5 ± 3.0||96.5 ± 1.4||50.8 ± 1.4bc||44.3 ± 3.8bc||82.7 ± 2.4d|
|EC50 (Hz)||85.0 ± 1.7||97.1 ± 1.5a||76.0 ± 1.7||88.2 ± 0.9||140.1 ± 1.5c||94.5 ± 2.4||82.0 ± 2.3|
|n coefficient||6.53 ± 0.2||5.83 ± 0.2||6.65 ± 0.2||6.62 ± 0.2||6.38 ± 0.2||4.54 ± 0.2e||5.82 ± 0.3|
Performing 150 eccentric contractions injured the anterior crural muscles as evidenced by long-lasting maximal strength deficits. Peak isometric twitch torque was reduced immediately (92.1 ± 0.8%; P < 0.001) and 3 (86.3 ± 4.1%; P < 0.001) days after eccentric exercise, and peak isometric tetanic torque (i.e., 300 Hz) was reduced immediately (51.6 ± 1.3%; P < 0.001), 3 (60.7 ± 3.9; P < 0.001), and 14 (16.1 ± 2.6%; P = 0.003) days after exercise (Fig. 2D, Table 1). The isometric twitch and tetanic strength deficits were greater (P < 0.001) after performance of eccentric than concentric contractions. The slope coefficient (n) of the isometric torque–stimulation frequency relationship was significantly (P < 0.001) less than preinjury by 3 days and returned to normal by 14 days (P = 0.24; Fig. 2D, Table 1). EC50 was greater (P < 0.001) than preinjury immediately after the eccentric and concentric contraction protocols, and had returned to normal values by 3 (P ≥ 0.08) days after both exercise protocols and remained unchanged (P = 0.22) 14 days posteccentric contractions (Table 1).
Ex vivo EDL muscle force after 150 eccentric or concentric contractions
Similar to anterior crural muscle function, EDL muscle experienced modest low-frequency fatigue following 150 concentric contractions. Peak isometric twitch force (Pt) and the slope coefficient of the force–stimulation frequency relationship were less (P ≤ 0.007) than uninjured control muscle immediately after concentric exercise, whereas peak isometric tetanic force (Po), EC50, change in resting tension, and peak caffeine contracture force were not different (P ≥ 0.17) than controls at this time (Fig. 3A, Table 2). By 3 days after concentric exercise, minor contractile dysfunction was still evident by decreases (P ≤ 0.02) in Po (15%) and the slope coefficient compared to control muscles.
|0 day||3 day||0 day||3 day||14 day|
|EDL (mg)||9.6 ± 0.3||11.9 ± 0.2a||11.1 ± 0.3a||11.8 ± 0.2a||12.0 ± 0.3a||10.7 ± 0.2|
|Lo (cm)||1.40 ± 0.01||1.44 ± 0.02||1.41 ± 0.01||1.38 ± 0.02||1.41 ± 0.03||1.42 ± 0.02|
|Minmeas (N cm−2)||3.86 ± 0.2||2.89 ± 0.2a||3.55 ± 0.2||0.87 ± 0.1b||1.88 ± 0.1b||3.21 ± 0.2|
|Maxmeas (N cm−2)||24.9 ± 0.7||22.7 ± 0.8||21.3 ± 1.1a||7.0 ± 0.6b||9.7 ± 0.5b||20.1 ± 0.9a|
|Minestim (N cm−2)||3.85 ± 0.2||2.8 ± 0.1a||3.6 ± 0.2||0.9 ± 0.1b||1.4 ± 0.1b||3.2 ± 0.2|
|Maxestim (N cm−2)||24.8 ± 0.6||23.1 ± 0.7||21.5 ± 1.1a||7.5 ± 0.7b||10.2 ± 0.5b||20.3 ± 0.9a|
|EC50 (Hz)||91.4 ± 1.7||85.3 ± 3.6||83.6 ± 3.5||116.1 ± 5.3b||109.0 ± 4.8b||86.1 ± 1.1|
|n coefficient||4.2 ± 0.1||2.9 ± 0.04a||3.5 ± 0.1a||3.0 ± 0.1a||3.0 ± 0.1a||3.5 ± 0.1a|
|50 mmol L−1 Caffeine (N cm−2)||6.5 ± 0.25||6.1 ± 0.14||6.3 ± 0.24||4.7 ± 0.15a||4.8 ± 0.12a||6.5 ± 0.2|
|50 mmol L−1 Caf/Po||27.3 ± 0.73||26.4 ± 0.51||30.0 ± 1.20||70.0 ± 4.35c||50.6 ± 1.93d||32.6 ± 1.03|
The performance of eccentric contractions caused significant injury to the EDL muscle. Pt and Po were 79% and 72% less (P < 0.001) than uninjured control EDL muscles immediately after exercise, respectively, and these strength deficits of 62–65% persisted (P < 0.001) through 3 days (Fig. 3B, Table 2). Moreover, the strength deficits caused by eccentric contractions were greater (P < 0.001) than those produced by concentric contractions. Muscle function improved by 14 days after injury induction, but Pt and Po were still less (P ≤ 0.03) than uninjured control values. Compared with uninjured muscle, the slope coefficient of the force–stimulation frequency relationship was significantly (P < 0.001) reduced immediately, 3 and 14 days after eccentric exercise. EC50 was greater (P ≤ 0.03) in EDL muscles that performed eccentric contractions than control and concentric exercise immediately and 3 days after injury.
Subjecting uninjured EDL muscles to 2 mmol L−1 caffeine causes minor increases (P = 0.03) in resting tension but does not result in significant (P = 0.72) potentiation of the 40 Hz contractile response (Fig. 3C and D). The increase in resting tension (72 ± 6.8%) observed immediately after eccentric contractions was significantly (P ≤ 0.003) greater than all other conditions (26–35%). Although peak submaximal isometric force was not augmented (P ≥ 0.29) by 2 mmol L−1 caffeine in EDL muscles from control and concentric contraction conditions, this submaximal force increased (P ≤ 0.04) immediately (34.1%) and 3 days (16.1%) after performing eccentric contractions. Peak 50 mmol L−1 caffeine contracture force was significantly (P < 0.001) lower immediately and 3 days after eccentric contractions compared with caffeine force from control and concentric muscles (Table 2). When comparing peak caffeine contracture and isometric tetanic force deficits to estimate E-C coupling failure (Ingalls et al. 1998b; Corona et al. 2010), approximately 44% and 49% of the isometric force deficits observed immediately and 3 days injury induction, respectively is explained by EC uncoupling.
Muscle wet weights and protein contents
Swelling of the anterior crural muscles is a characteristic of exercise-induced muscle injury and is reflected by changes in wet weight of muscle in this study. When compared to its contralateral control muscle, the injured TA muscle exhibited greater (P ≤ 0.007) wet weight at 0 and 3 days after performance of eccentric contractions, whereas control muscles exhibit no difference (P = 0.22) in their weights (data not shown). In general, the left EDL and TA muscle wet weights of the control mice were significantly (P ≤ 0.04) less than the weights of nearly all other groups except for muscles that were allowed to recover 14 days (P ≥ 0.62) after eccentric contractions (Tables 2 and 3). There were no significant differences (P ≥ 0.55) in absolute (mg per muscle) or relative (% of wet weight) total protein content of TA muscles among the control, concentric, or eccentric groups (Table 3). Compared with control TA muscle, there was a significant (P = 0.02) decrease in relative pellet protein content 3 days after eccentric contractions (Table 3). Absolute soluble protein content of TA muscles was significantly reduced (P ≤ 0.02) 14 days after eccentric contractions compared to all other groups except for control (P = 0.12). In contrast, relative soluble protein content of TA muscles was only significantly (P ≤ 0.03) reduced 14 days after eccentric contractions compared to concentric contractions but not the other eccentric contraction (P ≥ 0.15) or control (P = 0.06) groups (Table 3).
|0 day||3 day||0 day||3 day||14 day|
|TA muscle weight (mg)||40.9 ± 0.9||40.9 ± 0.8||43.4 ± 0.6a||44.2 ± 0.6a||45.4 ± 0.5a||40.9 ± 1.3|
|TA/body weight (mg g−1)||1.8 ± 0.03||1.7 ± 0.06||1.8 ± 0.04||1.8 ± 0.04||1.9 ± 0.04b||1.7 ± 0.04|
|TA total protein (mg per muscle)||14.6 ± 0.6||13.6 ± 0.9||14.9 ± 1.0||15.2 ± 0.5||15.2 ± 0.7||13.4 ± 0.6|
|TA total protein (% wet wt.)||35.3 ± 1.3||32.9 ± 2.2||34.3 ± 2.4||35.2 ± 1.1||33.3 ± 1.4||32.0 ± 1.2|
|TA pellet protein (mg per muscle)||6.0 ± 0.3||5.6 ± 0.7||6.6 ± 0.8||5.8 ± 0.3||4.8 ± 0.5||5.4 ± 0.7|
|TA pellet protein (% wet wt.)||15.2 ± 0.8||13.9 ± 2.2||15.1 ± 1.9||13.3 ± 0.9||10.5 ± 1.2a||12.9 ± 1.1|
|TA soluble protein (mg per muscle)||5.0 ± 0.1||5.3 ± 0.1||5.5 ± 0.1||5.3 ± 0.2||5.3 ± 0.2||4.4 ± 0.3c|
|TA soluble protein (% wet wt.)||12.1 ± 0.2||12.8 ± 0.3||12.6 ± 0.4||12.1 ± 0.4||11.7 ± 0.5||10.6 ± 0.6d|
We estimate that approximately 60% of the FKBP12 was found in the pellet fraction, which is in agreement with observations that approximately 60–75% of FKBP12 is normally found in the pellet fraction after centrifugation in mouse skeletal muscle (Susan Hamilton, unpublished observation). FKBP12 content in the pellet fraction normalized to actin protein was not significantly different between control and concentric muscles (P = 0.11). However, the performance of eccentric contractions resulted in a 43% decrease (P = 0.02) in normalized FKBP12 content in the pellet fraction immediately after the eccentric contractions (Figs. 3D, 4B). Normalized FKBP12 content in the pellet had returned to control values by 3 and 14 days (P ≥ 0.51; Figs. 3D, 4B).
FKBP12 content in the supernatant fraction normalized to GAPDH protein was not significantly different between control and concentric muscles (P = 0.61). Although eccentric contractions did not affect normalized FKBP12 content immediately after exercise, it was significantly (P = 0.03) elevated 52% by 3 days postinjury and then had returned to control values by 14 days (P = 0.65; Fig 4A and C).
FKBP12 content in the pellet fraction immediately after injury induction was correlated (P = 0.025) with deficits in maximal isometric torque (R2 = 0.38). However, there were no significant (P ≥ 0.32) correlations between FKBP12 content and isometric strength when analyzed over all the time points.
Unaccustomed exercise that requires significant use of eccentric contractions is known to induce focal damage to force-generating (i.e., sarcomeres) and transmitting (i.e., cytoskeleton) structures. Increasing evidence indicates that eccentric contractions can also damage triad and E-C coupling structures (Warren et al. 1993, 1995, 1999, 2002b; Balnave and Allen 1995; Takekura et al. 2001; Yeung et al. 2002; Corona et al. 2010). Given the various loci of cellular damage and long duration of functional impairment, strength deficits associated with eccentric contraction-induced muscle injury most certainly stem from multiple mechanisms. However, it appears that damage to E-C coupling components is immediate and pervasive within skeletal muscle following injurious exercise, accounting for significant deficits in skeletal muscle force production (Warren et al. 1993; Balnave and Allen 1995; Ingalls et al. 1998b; Corona et al. 2010). The primary findings of this study indicate that FKBP12 content within skeletal muscles of mice is disrupted by the performance of eccentric contractions. Given the role of FKBP12 in regulating RyR1 function, it is not surprising that immediate reductions in FKBP12 content are correlated with decreases in skeletal muscle function.
In this study, regression analysis indicates that 38% of the variability in isometric tetanic torque immediately after the eccentric contraction bout can be accounted for by changes in FKBP12 in the pellet fraction. We have shown that eccentric contractions reduce both voltage-gated SR Ca2+ release and drug-induced SR Ca2+ release rates immediately after exercise (Ingalls et al. 1998b). Moreover, decreases in FKBP12 content has been shown to impair voltage-gated SR Ca2+ release in myotubes (Avila et al. 2003; Tang et al. 2004). A loss of FKBP12 from RyR1 has also been associated with strength deficits associated with muscle fatigue resulting from chronic exhaustive exercise (Bellinger et al. 2008). In contrast to these findings, we previously demonstrated that muscle-specific knockdown of FKBP12 from birth resulted in less isometric tetanic force deficits immediately after eccentric contractions in EDL muscles from adult mice (Corona et al. 2008b). It is possible that adaptions in the EDL muscle to the long-term reduction in FKBP12 contributed to the resistance to eccentric contraction-induced muscle injury. In support of this idea, muscle-specific knockdown of FKBP12 is associated with an upregulation of the slow myofiber phenotype (Tang et al. 2004), which is less susceptible to eccentric contraction-induced muscle injury (Warren et al. 1994).
The decrease in FKBP12 content in the pellet fraction immediately after the performance of eccentric contractions also occurred at the same time that resting tension in the EDL muscle was disrupted. The 72% increase in resting tension during the 2 mmol L−1 caffeine exposure likely results from increases in resting cytosolic [Ca2+], which may stem from leaky RyR1 channels. Bellinger et al. (2008) reported that the exhaustive exercise eliminated FKBP12 from RyR1 resulting in leaky SR Ca2+ channels and reduced SR Ca2+ stores. We have shown that resting free cytosolic Ca2+ concentration is increased immediately after eccentric contraction-induced muscle injury (Ingalls et al. 1998b). Elevated cytosolic Ca2+ may have contributed to enhanced submaximal contractile potentiation observed in the EDL muscle during the 2 mmol L−1 caffeine exposure immediately after injury induction by increasing Ca2+-calmodulin mediated myosin light chain phosphorylation. To this end, Rijkelijkhuizen et al. (2005) reported that the magnitude of submaximal contractile potentiation was approximately doubled compared to uninjured rat skeletal muscle after the performance of eccentric contractions.
Alterations in FKBP12 content in the TA muscle may stem from posttranslational modification (e.g., phosphorylation, S-nitrosylation) or enzymatic cleavage of RyR1, which removes FKBP12 from the RyR1 subunit. Once removed from RyR1, FKBP12 may be lost from the myofiber similar to other muscle proteins (e.g., CK, LDH, and MHC) presumably via disruptions in the integrity of T-tubule and plasma membranes (Warren et al. 1995; Takekura et al. 2001; Yeung et al. 2002). RyR1 is a known substrate for Ca2+-dependent proteolysis (Gilchrist et al. 1992; Wu et al. 1997; Shevchenko et al. 1998). Moreover, Murphy et al. (2013) have recently shown that supraphysiological activation of skeletal muscle results in Ca2+-dependent proteolysis of JP1 and 2, and impaired voltage-gated SR Ca2+ release. Although eccentric contraction-induced muscle injury is associated with elevated cytosolic Ca2+ and calpain activation, pharmacological manipulation of Ca2+ in our mouse model has not affected the magnitude of injury or force deficits (Lowe et al. 1994; Warren et al. 2002a; Ingalls et al. 2004).
Previous reports indicate that chronic fatigue in mouse skeletal muscle is associated with FKBP12 depletion from RyR1 via increased phosphorylation and/or S-nitrosylation of RyR1 (Bellinger et al. 2008). Moreover, intense cycling exercise in humans resulted in increased levels of phosphorylation and nitrosylation of RyR1, and FKBP12 depletion of RyR1 in quadriceps muscle (Bellinger et al. 2008). A single bout of maximal eccentric contractions has also been shown to increase phosphorylation of RyR1 in human skeletal muscle for 30 min after the exercise (Gehlert et al. 2012). The extent of phosphorylation and S-nitrosylation of the RyR1 in mouse skeletal muscle after performance of eccentric contractions is unknown. Although our previous work indicates that nitric oxide synthesis protects skeletal muscle from exacerbation of strength deficits in our mouse injury model (Corona and Ingalls 2013), it is possible that eccentric contractions promotes phosphorylation and/or S-nitrosylation of RyR1 and may alter FKBP12-RyR1 binding.
Three days after injury induction, FKBP12 content in the supernatant was significantly increased and content in the pellet fraction returned to normal values (Fig. 4). Although this change in FKBP12 content did not affect voltage-gated force output in injured skeletal muscle at this time, the increase in resting tension observed during exposure to 2 mmol L−1 caffeine was significantly reduced. Moreover, it is possible that the return of FKBP12 in segments of the myofiber that are not undergoing phagocytosis at 3–5 days may facilitate the recovery in E-C uncoupling and explain paradoxical recovery of peak isometric force at a time when myofibrillar protein is being lost (Ingalls et al. 1998a). Bellinger et al. (2008) reported that drug treatment designed to restore FKBP12 binding to RyR1 was effective at preventing exercise-induced increases in RyR1 open probability and minimizing strength loss associated with fatigue. The increase in FKBP12 at 3 days postinjury is consistent with observed increases in other proteins associated with E-C coupling after eccentric contraction-induced muscle injury. We have demonstrated that the nicotinic acetylcholine (Warren et al. 1999) and dihydropyridine (Ingalls et al. 2004) receptors are also upregulated 3–5 days after injury induction. Although we observe enhanced mTORc1 and p70s6k signaling activity 3 days after injury induction (unpublished observation), whether the increases in FKBP12 and nicotinic acetylcholine and DHPRs at this time reflect increased translation or gene expression awaits further study. Nonetheless, the apparent increase in critical E-C coupling proteins may contribute to the enhanced recovery rate of E-C coupling failure, while regeneration of damaged sarcomeres appears to take weeks and requires satellite cell involvement (Lowe et al. 1995; Rathbone et al. 2003).
In summary, we document that the content of FKBP12 within anterior crural muscle is reduced immediately after inducing eccentric contraction-induced muscle injury and that this reduction is significantly correlated with voltage-gated force production. The observation that FKBP12 content is elevated in the supernatant fraction and restored in the pellet fraction 3 days after injury may suggest that FKBP12 restoration is associated with the relative rapid recovery of E-C uncoupling compared to the slow restoration of damaged myofibrillar protein. Although we have demonstrated that reductions in junctophilin (Corona et al. 2010) and FKBP12 appear to cause some of the strength deficits associated with eccentric contraction-induced muscle injury, it is possible that other proteins interacting with the RyR1 may also be disrupted and their loss also contributes to impaired SR Ca2+ release and/or force production.
Conflict of Interest
- 1997. Subconductance states in single-channel activity of skeletal muscle ryanodine receptors after removal of FKBP12. Biophys. J. 72:146–162. , , and .
- 2005. Mechanisms of stretch-induced muscle damage in normal and dystrophic muscle: role of ionic changes. J. Physiol. 567:723–735. , , and .
- 2003. FKBP12 binding to RyR1 modulates excitation-contraction coupling in mouse skeletal myotubes. J. Biol. Chem. 278:22600–22608. , , , , and .
- 1995. Intracellular calcium and force in single mouse muscle fibres following repeated contractions with stretch. J. Physiol. 488:25–36. , and .
- 2008. Remodeling of ryanodine receptor complex causes “leaky” channels: a molecular mechanism for decreased exercise capacity. Proc. Natl. Acad. Sci. USA 105:2198–2202. , , , , , , et al.
- 1994. Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein. Cell 77:513–523. , , , , , , et al.
- 2004. Regulation of ryanodine receptors by FK506 binding proteins. Trends Cardiovasc. Med. 14:227–234. , , , and .
- 2002. Exercise-induced muscle damage in humans. Am. J. Phys. Med. Rehabil. 81(Suppl):S52–S69. , and .
- 2013. Nitric oxide synthase inhibition increases immediate force loss after eccentric contractions. Muscle Nerve 47:271–273. , and .
- 2008a. Eccentric contractions do not induce rhabdomyolysis in malignant hyperthermia susceptible mice. J. Appl. Physiol. 105:1542–1553. , , , and .
- 2008b. FKBP12 deficiency reduces strength deficits after eccentric contraction-induced muscle injury. J. Appl. Physiol. 105:527–537. , , , and .
- 2010. Junctophilin damage contributes to early strength deficits and EC coupling failure after eccentric contractions. Am. J. Physiol. Cell Physiol. 298:C365–C376. , , , , , and .
- 2012. Intense resistance exercise induces early and transient increases in ryanodine receptor 1 phosphorylation in human skeletal muscle. PLoS One 7:e49326. , , , , , , et al.
- 1992. Calcium activated neutral protease effects upon skeletal muscle sarcoplasmic reticulum protein structure and calcium release. J. Biol. Chem. 267:20857–20865. , , , and .
- 2011. Junctophilin 1 and 2 proteins interact with the L-type Ca2+ channel dihydropyridine receptors (DHPRs) in skeletal muscle. J. Biol. Chem. 286:43717–43725. , , , , , , et al.
- 1999. Caffeine and excitation-contraction coupling in skeletal muscle: a stimulating story. J. Muscle Res. Cell. Motil. 20:223–237. , , and .
- 2006. Uncoupling store-operated Ca2+ entry and altered Ca2+ release from sarcoplasmic reticulum through silencing of junctophilin genes. Biophys. J. 90:4418–4427. , , , , , , et al.
- 2013. Lengthening our perspective: morphological, cellular, and molecular responses to eccentric exercise. Muscle Nerve 49:155–170. , and .
- 1998a. Dissociation of force production from MHC and actin contents in muscles injured by eccentric contractions. J. Muscle Res. Cell Motil. 19:215–224. , , and .
- 1998b. E-C coupling failure in mouse EDL muscle after in vivo eccentric contractions. J. Appl. Physiol. 85:58–67. , , , , and .
- 2004. Dihydropyridine and ryanodine receptor binding after eccentric contractions in mouse skeletal muscle. J. Appl. Physiol. 96:1619–1625. , , , , and .
- 2001. Deficiency of triad junction and contraction in mutant skeletal muscle lacking junctophilin type 1. J. Cell Biol. 154:1059–1067. , , , , , , et al.
- 2002. Deficiency of triad formation in developing skeletal muscle cells lacking junctophilin type 1. FEBS Lett. 524:225–229. , , , and .
- 2010. Ryanodine receptor studies using genetically engineered mice. FEBS Lett. 584:1956–1965. , , and .
- 2001. Different Ca2+ releasing action of caffeine and depolarisation in skeletal muscle fibres of the rat. J. Physiol. 531:715–728. , , and .
- 2010. Ryanodine receptors: structure, expression, molecular details, and function in calcium release. Cold Spring Harb. Perspect. Biol. 2:a003996. , , , and .
- 1994. Eccentric contraction-induced injury of mouse soleus muscle: effect of varying [Ca2+]o. J. Appl. Physiol. 76:1445–1453. , , , , and .
- 1995. Muscle function and protein metabolism after initiation of eccentric contraction-induced injury. J. Appl. Physiol. 79:1260–1270. , , , , and .
- 1997. Quantitative measurement of resting skeletal muscle [Ca2+]i following acute and long-term downhill running exercise in mice. Cell Calcium 22:373–383. , , and .
- 2013. Ca2+-dependent proteolysis of junctophilin-1 and junctophilin-2 in skeletal and cardiac muscle. J. Physiol. 591:719–729. , , , , , and .
- 2003. Importance of satellite cells in the strength recovery after eccentric contraction-induced muscle injury. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285:R1490–R1495. , , , and .
- 2005. Low-frequency fatigue, post-tetanic potentiation and their interaction at different muscle lengths following eccentric exercise. J. Exp. Biol. 208:55–63. , , , and .
- 1998. Identification, characterization and partial purification of a thiol-protease which cleaves specifically the skeletal muscle ryanodine receptor/Ca2+ release channel. J. Membr. Biol. 161:33–43. , , , and .
- 2001. Eccentric exercise-induced morphological changes in the membrane systems involved in excitation-contraction coupling in rat skeletal muscle. J. Physiol. 533:571–583. , , , , and .
- 2004. Altered excitation-contraction coupling with skeletal muscle specific FKBP12 deficiency. FASEB J. 18:1597–1599. , , , , , , et al.
- 1993. Excitation failure in eccentric contraction-induced injury of mouse soleus muscle. J. Physiol. 468:487–499. , , , , , and .
- 1994. Eccentric contraction-induced injury in normal and hindlimb-suspended mouse soleus and EDL muscles. J. Appl. Physiol. 77:1421–1430. , , , , and .
- 1995. Redistribution of cell membrane probes following contraction-induced injury of mouse soleus muscle. Cell Tissue Res. 282:311–320. , , , , and .
- 1999. Uncoupling of in vivo torque production from EMG in muscles injured by eccentric contractions. J. Physiol. 515:609–619. , , , and .
- 2002a. Temperature dependency of force loss and Ca2+ homeostasis in mouse EDL muscle after eccentric contractions. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282:R1122–R1132. , , and .
- 2002b. What mechanisms contribute to the strength loss that occurs during and in the recovery from skeletal muscle injury? J. Orthop. Sports Phys. Ther. 32:58–64. , , , and .
- 1997. Functional interactions between cytoplasmic domains of the skeletal muscle Ca2+ release channel. J. Biol. Chem. 272:25051–25061. , , , , , and .
- 2002. Development of T-tubular vacuoles in eccentrically damaged mouse muscle fibres. J. Physiol. 540:581–592. , , , , and .